Agenzia Italiana del Farmaco
home
Highlights
News
16 Nov 2026
Transparency Lists
AIFA updates the Transparency Lists
16 Nov 2026
Medicine shortages
Definitive cessation of marketing of Emend (aprepitant)
10 Nov 2026
Access to medicinal products
Extension of the temporary authorization for the use of haptens in patch testing in the absence of commercially available clinical alternatives
04 Nov 2026
Quality and Inspections
Direct communication with healthcare professionals on Respreeza
30 Oct 2026
Quality and Inspections
Direct communication with healthcare professionals on CAELYX/DOXIL
30 Oct 2026
National Pharmacovigilance Network
Correct completion of the medicinal product name and active substance fields in individual case safety reports (ICSRs) in accordance with the ICH E2B(R3) standard
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology